- Merck & Co. (South San Francisco, CA)
- …department is recruiting a Senior Director, who will serve as the Computational Biology lead for Cardiometabolic Drug Discovery Data Science. We are seeking ... our Company's investments in human genetics and other multimodal data to support drug discovery in the cardiometabolic disease space. This work will help… more
- Merck & Co. (Rahway, NJ)
- Job DescriptionThe Principal Scientist, Drug Discovery in our Research and Development Department will be responsible for identifying new molecular entities and ... a key driver to advance novel targets and will lead these research programs from ideation through the early...of 8 years industry or pharmaceutical research experience in drug discovery or preclinical research with a… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Merck & Co. (South San Francisco, CA)
- …this role, you will: Lead a team of scientists in SSF Discovery Biologics focused on macromolecular interactions, cell based functional characterization, and ... world's premier, most research-intensive biopharmaceutical company. Our teams combine leading drug discovery capabilities and world-class R&D with the purpose… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Piscataway, NJ)
- …pipeline efforts. The successful candidate will be part of Legend Biotech, a leading cell therapy company with commercial CAR drug product CARVYKTI and an ... diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Merck & Co. (Rahway, NJ)
- …To achieve our goals, we work closely with colleagues in Discovery , Pre-clinical, Early Development, Analytical, Formulation, and Commercial Manufacturing, all ... and collaborative team of scientists and engineers to design upstream, cell -culture processes while developing technical strategies related to upstream processing… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous ... and allogenic chimeric antigen receptor T- cell , T- cell receptor (TCR-T), and natural killer...world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients… more
